Rana Atique Anwer, Sajid Ghafor, Huma Ahmad. “Neoadjuvant Docetaxel Plus Carboplatin Versus Epirubicin Plus Cyclophosphamide Followed by Docetaxel in Triple-Negative, Early-Stage Breast Cancer”. Pakistan Journal of Medical & Health Sciences 16, no. 08 (September 20, 2022): 356. Accessed September 27, 2024. https://pjmhsonline.com/index.php/pjmhs/article/view/2384.